2022
COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study
ARKADIUSZ, Dziedzic; Julien ISSA; Mohammad Salman HUSSAIN; Tanasiewicz MARTA; Wojtyczka ROBERT et. al.Basic information
Original name
COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study
Authors
ARKADIUSZ, Dziedzic; Julien ISSA; Mohammad Salman HUSSAIN (356 India, belonging to the institution); Tanasiewicz MARTA; Wojtyczka ROBERT; Kubina ROBERT; Konwinska Marta DYSZKIEWICZ and Abanoub RIAD (818 Egypt, guarantor, belonging to the institution)
Edition
Frontiers in Public Health, LAUSANNE, FRONTIERS MEDIA SA, 2022, 2296-2565
Other information
Language
English
Type of outcome
Article in a journal
Field of Study
30304 Public and environmental health
Country of publisher
Switzerland
Confidentiality degree
is not subject to a state or trade secret
References:
Impact factor
Impact factor: 5.200
RIV identification code
RIV/00216224:14110/22:00126335
Organization unit
Faculty of Medicine
UT WoS
000891406400001
EID Scopus
2-s2.0-85135537206
Keywords in English
cross-sectional studies; COVID-19 vaccines; decision making; healthcare professionals; vaccination hesitancy; Poland
Tags
International impact, Reviewed
Changed: 5/4/2023 08:17, Mgr. Tereza Miškechová
Abstract
V originále
Since healthcare professionals (HCPs) play a critical role in shaping their local communities' attitudes toward vaccines, HCPs' beliefs and attitudes toward vaccination are of vital importance for primary prevention strategies. The present study was designed as a cross-sectional survey-based study utilizing a self-administered questionnaire to collect data about COVID-19 vaccine booster hesitancy (VBH) among Polish HCPs and students of medical universities (MUSs). Out of the 443 included participants, 76.3% were females, 52.6% were HCPs, 31.8% were previously infected by SARS-CoV-2, and 69.3% had already received COVID-19 vaccine booster doses (VBD). Overall, 74.5% of the participants were willing to receive COVID-19 VBD, while 7.9 and 17.6% exhibited their hesitance and rejection, respectively. The most commonly found promoter for acceptance was protection of one's health (95.2%), followed by protection of family's health (81.8%) and protection of community's health (63.3%). Inferential statistics did not show a significant association between COVID-19 VBH and demographic variables, e.g., age and gender; however, the participants who had been previously infected by SARS-CoV-2 were significantly more inclined to reject the VBD. Protection from severe infection, community transmission, good safety profile, and favorable risk-benefit ratio were the significant determinants of the COVID-19 VBD acceptance and uptake. Fear of post-vaccination side effects was one of the key barriers for accepting COVID-19 VBD, which is consistent with the pre-existing literature. Public health campaigns need to highlight the postulated benefits of vaccines and the expected harms of skipping VBD.
Links
EF18_053/0016952, research and development project |
| ||
EF19_073/0016943, research and development project |
| ||
MUNI/A/1402/2021, interní kód MU |
| ||
MUNI/IGA/1104/2021, interní kód MU |
|